Compares treatment options for Intrauterine Adhesion
Official title Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
ClinicalTrials.gov ID: NCT05257213
What this study is testing
What is Heparin solution?
Heparin solution is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for intrauterine adhesion.
Also referred to as HEP.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to compare the efficacy of intrauterine application of heparin solution to the use of hyaluronic acid barrier gel for the prevention of intrauterine adhesion formation after operative hysteroscopy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 50, women only
You may be able to join if
- female sex
- indication for operative hysteroscopy including one or more of the following:
- infertility,
- irregular bleeding,
- oligo-/amenorrhea,
You likely can't join if
- ongoing pregnancy,
- genital cancer,
- pelvic inflammatory disease,
- excessive uterine bleeding.
See the full eligibility criteria
- female sex
- indication for operative hysteroscopy including one or more of the following:
- infertility,
- irregular bleeding,
- oligo-/amenorrhea,
- Asherman syndrome,
- G0-G3 fibroids,
- dysmorphic uterus.
- ongoing pregnancy,
- genital cancer,
- pelvic inflammatory disease,
- excessive uterine bleeding.
The study team makes the final eligibility decision.
Where it's taking place
- Sofia, Sofia, Bulgaria
- Sofia, Bulgaria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sofia, Sofia, Bulgaria; Sofia, Bulgaria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.